48 results on '"Bentink, Stefan"'
Search Results
2. PRELIMINARY ASSESSMENT OF A VALIDATED URINE EXOSOME ASSAY (EXDX PROSTATE (INTELLISCORE) FOR PREDICTING BIOCHEMICAL RECURRENCE POST-PROSTATECTOMY: PI-LBA08
3. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
4. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
5. Detecting Common Gene Expression Patterns in Multiple Cancer Outcome Entities
6. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
7. iBBiG: iterative binary bi-clustering of gene sets
8. High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas
9. Detecting hierarchical structure in molecular characteristics of disease using transitive approximations of directed graphs
10. Abstract 2795: Dissemination score of CD8+ TILs by automated image analysis is a potential marker of immune activity in human cancers
11. Abstract LB-B03: Exosome-based Detection ofEGFRT790M in Plasma from Non-Small Cell Lung Cancer Patients
12. P130 An algorithm to detect and quantify low frequency HLA-genotypes in NGS data
13. P108 Phased whole-gene characterization of novel KIR3DL1 , KIR3DL2 , and KIR3DL3 alleles using a dual redundant sequencing strategy
14. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
15. PI-LBA08 PRELIMINARY ASSESSMENT OF A VALIDATED URINE EXOSOME ASSAY (EXDX PROSTATE (INTELLISCORE) FOR PREDICTING BIOCHEMICAL RECURRENCE POST-PROSTATECTOMY
16. A non-invasive urine exosome gene expression assay (ExoIntelliScore Prostate) to predict pathologic stage and grade in the prostatectomy specimen.
17. Extended analysis of a validated urine-exosome signature to predict high grade prostate cancer on initial biopsy: Performance across multiple sub-groups.
18. Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients
19. Interim performance of a non-DRE urine exosome gene signature to predict Gleason ≥7 prostate cancer on initial prostate needle biopsy from patients enrolled in a prospective observational trial.
20. PII-LBA2 VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA.
21. A first catch, non-DRE urine exosome gene signature to predict Gleason 7 prostate cancer on an initial prostate needle biopsy.
22. Transcriptional profiling of aggressive lymphoma
23. Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes
24. Abstract B34: Development of a urine microvesicle/exosome RNA biomarker panel to identify prostate cancer.
25. 2053 URINARY EXOSOMES/MICROVESICLES AS A NON-INVASIVE PLATFORM FOR PROSTATE CANCER ANALYSIS
26. Abstract LB-108: Exosome profiling of mRNAs and miRNAs in serum samples from GBM patients .
27. Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
28. SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
29. SOCS1 Mutation Subtypes Predict Divergent Outcomes in DLBCL Patients
30. Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
31. Abstract C140: RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and ovarian cancer.
32. Abstract C139: Detection of BRAF mutations in serum/plasma microvesicles (exosomes) of malignant melanoma patients.
33. High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas
34. Therapeutic Implications of GIPC1 Silencing in Cancer
35. Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status
36. CD30-Induced Signaling Is Absent in Hodgkin's Cells but Present in Anaplastic Large Cell Lymphoma Cells
37. Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain
38. SIMILARITIES OF ORDERED GENE LISTS
39. Potency of CD30 stimulation: analysis of anaplastic large cell lymphoma - and Hodgkin lymphoma cell lines
40. The Functional Basis of Mycophenolic Acid Resistance in Candida albicans IMP Dehydrogenase
41. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status.
42. Ataxia Telangiectasia-Mutated Gene Is a Possible Biomarker for Discrimination of Infiltrative Deep Penetrating Nevi and Metastatic Vertical Growth Phase Melanoma.
43. Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicansWild-Type Strain
44. Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
45. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients
46. SOCS1Mutation Subtypes Predict Divergent Outcomes in DLBCL Patients
47. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
48. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.